Japan To Establish iPS Medical Research Safety Guidelines

A research team at the Ministry of Health, Labor and Welfare is drafting guidelines addressing safety issues for using induced pluripotent stem cells in regenerative medicine. The guidelines will standardize issues related to generating and managing iPS cells for clinical studies; the purpose is to minimize adverse effects and carcinogenic risks. The Ministry aims to establish formal guidelines within 2010. It will be the world's first safety guidelines targeting iPS cells. (Click here for more - Japanese language